Prostate cancer: open trials in Romania

• NCT06136650

  A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  Spitalul Clinic De Urgenta Prof Dr Agrippa Ionescu, Baloteşti · Spitalul Clinic Prof.Dr.Theodor Burghele, Bucharest · Delta Health Care S.R.L, Bucharest · Spitalul Clinic Municipal Cluj-Napoca, Cluj-Napoca · Centrul De Oncologie SF Nectarie S.R.L., Craiova

  Registry updated 2026-10-20

• NCT04641247

  A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study

  Trial Treatment · Phase 2 · GlaxoSmithKline

  Centrul De Oncologie SF Nectarie S.R.L., Craiova

  Registry updated 2026-06-24

• NCT04916613

  ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable)

  Trial Treatment · Phase 3 · UNICANCER

  Institutul Oncologic Prof. Dr. Alexandru Trestioreanu Bucuresti, Bucharest · Institute Of Oncology Prof. Dr. Ion Chiricuta Cluj-Napoca, Cluj-Napoca · Radiotherapy Center Cluj S.R.L., Floresti · Oncomed S.R.L., Timisoara

  Registry updated 2026-04-28

• NCT04895839

  Predictors of Mental Health in Men With Prostate Cancer Undergoing a Patient Empowerment Program

  Trial Treatment · Gabriela Ilie

  Medisprof Cancer Center, Cluj-Napoca

  Registry updated 2026-03-18

• NCT05974774

  Intermittent Androgen Deprivation Therapy in the Era of AR Pathway Inhibitors

  Trial Treatment · Phase 3 · European Organisation for Research and Treatment of Cancer - EORTC

  Medisprof S.R.L., Cluj-Napoca · Oncomed S.R.L., Timisoara

  Registry updated 2025-09-19

All Prostate cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error